Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGT2B7 | P16662 | 1/20 | 0.62 |
| ▸ | CYP2D6 | P10635 | 4/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.62 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 1/20 | 0.62 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | ATM | Q13315 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 9/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 9/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 9/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.49 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10120474 | 1.00 | UGT2B7 (0.62) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL6933240 | 0.92 | LMNA (0.54) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL6055328 | 0.85 | MEN1 (0.58) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL3266869 | 0.83 | UGT2B7 (0.61) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL31036064 | 0.83 | MEN1 (0.57) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL6317871 | 0.83 | MEN1 (0.57) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL4912776 | 0.82 | HDAC1 (0.58) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL6543395 | 0.82 | CYP2D6 (0.59) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL2894556 | 0.82 | CYP2D6 (0.59) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 | |
| SCHEMBL6490271 | 0.82 | CYP2D6 (0.59) | UGT2B7CYP2D6MEN1KMT2ACYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112409845-A | Printing ink | TCL集团股份有限公司 | 2021-02-26 | — | — | CN | claimed |
| EP-4516824-B1 | POLYMER ELECTROLYTE PREPOLYMERIZATION SOLUTION, POLYMER ELECTROLYTE AND ELECTROCHEMICAL DEVICE | SHENZHEN BTR NEW ENERGY TECH RESEARCH INSTITUTE CO LTD (CN) | 2025-12-10 | — | — | EP | disclosed |
| US-12476279-B2 | Oligomer solution of polymer electrolyte, polymer electrolyte and electrochemical device | SHENZHEN BTR NEW ENERGY TECHNOLOGY RESEARCH INSTITUTE CO., LTD. (CN) | 2025-11-18 | — | — | US | disclosed |
| EP-4516824-A1 | POLYMER ELECTROLYTE PREPOLYMERIZATION SOLUTION, POLYMER ELECTROLYTE AND ELECTROCHEMICAL DEVICE | Shenzhen BTR New Energy Technology Research Institute Co., Ltd. (CN) | 2025-03-05 | — | — | EP | disclosed |
| US-20250023097-A1 | OLIGOMER SOLUTION OF POLYMER ELECTROLYTE, POLYMER ELECTROLYTE AND ELECTROCHEMICAL DEVICE | SHENZHEN BTR NEW ENERGY TECHNOLOGY RESEARCH INSTITUTE CO., LTD. (CN) | 2025-01-16 | — | — | US | disclosed |
| WO-2025007384-A1 | POLYMER ELECTROLYTE PREPOLYMERIZATION SOLUTION, POLYMER ELECTROLYTE AND ELECTROCHEMICAL DEVICE | 深圳市贝特瑞新能源技术研究院有限公司 | 2025-01-09 | — | — | WO | disclosed |
| WO-2024059951-A1 | INHIBITORS OF THE ANDROGEN RECEPTOR DNA-BINDING DOMAIN | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2024-03-28 | — | — | WO | disclosed |
| CN-116525935-B | Polymer electrolyte prepolymerization liquid, polymer electrolyte and electrochemical device | 深圳市贝特瑞新能源技术研究院有限公司 | 2024-01-12 | — | — | CN | disclosed |
| CN-116525935-A | Polymer electrolyte prepolymerization liquid, polymer electrolyte and electrochemical device | 深圳市贝特瑞新能源技术研究院有限公司 | 2023-08-01 | — | — | CN | disclosed |
| US-20220324865-A1 | SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2022-10-13 | — | — | US | disclosed |
| US-20070265255-A1 | SYNTHESIS, STRUCTURE AND USE OF BISOXAZOLIDINES FOR ASYMMETRIC CATALYSIS AND SYNTHESIS | GEORGETOWN UNIVERSITY | 2007-11-15 | — | — | US | disclosed |
| US-7153971-B2 | Contacting a carbohydrate with an amine to produce amino tetrahydroxy carbohydrate, protecting two hydroxy groups of tetrahydroxy carbohydrate, forming hydroxy heterocyclic-spiro moiety by reacting with activated carbonate, oxidizing OH | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2006-12-26 | — | — | US | disclosed |
| EP-1300381-B1 | Process for preparing optically active alcohols | JAPAN SCIENCE & TECH AGENCY (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-6887820-B1 | For producing optically active secondary alcohols, producing optically active compounds useful for various utilities such as intermediates for synthesizing pharmaceutical agents, liquid crystal materials and agents for optical resolution | JAPAN SCIENCE AND TECHNOLOGY CORPORATION (JP) | 2005-05-03 | — | — | US | disclosed |
| EP-1317460-A4 | COMPOUNDS CONTAINING OXAZOLIDINONE MOIETY AND USES THEREOF | UNIV COLORADO STATE RES FOUND (US) | 2005-04-20 | — | — | EP | disclosed |
| EP-1317460-A1 | COMPOUNDS CONTAINING OXAZOLIDINONE MOIETY AND USES THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2003-06-11 | — | — | EP | disclosed |
| EP-1300381-A1 | Process for preparing optically active alcohols | Japan Science and Technology Corporation (JP) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002018391-A1 | COMPOUNDS CONTAINING OXAZOLIDINONE MOIETY AND USES THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION (US) | 2002-03-07 | — | — | WO | disclosed |
| US-6184381-B1 | USEFUL AS INTERMEDIATES FOR SYNTHESIZING PHARMACEUTICAL CHEMICALS, LIQUID CRYSTAL MATERIALS AND AGENTS FOR OPTICAL RESOLUTION, REDUCTION, KETONES TO ALCOHOL, IMINES TO AMINES | JAPAN SCIENCE & TECHNOLOGY CORP. (JP) | 2001-02-06 | — | — | US | disclosed |
| EP-0916637-A1 | PROCESS FOR PREPARATING OPTICALLY ACTIVE COMPOUNDS | Japan Science and Technology Corporation (JP) | 1999-05-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220324865-A1 | SUBSTITUTED DIHYDROPYRAZOLO PYRAZINE CARBOXAMIDE DERIVATIVES | QDPR, SIRT5, PDXK | UGT2B7 214/4885CYP2D6 173/4885MEN1 2223/4885 |
| US-20070265255-A1 | SYNTHESIS, STRUCTURE AND USE OF BISOXAZOLIDINES FOR ASYMMETRIC CATALYSIS AND SYNTHESIS | ADH5, ADH1C, ADH1A | UGT2B7 571/4885CYP2D6 244/4885MEN1 3214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.